+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid udca and its conjugates decrease lymphocyte proliferation to mitogenic stimuli through different mechanisms



Ursodeoxycholic acid udca and its conjugates decrease lymphocyte proliferation to mitogenic stimuli through different mechanisms



Gastroenterology 102(4 Part 2): A931




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144936

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid udca and its conjugates decrease lymphocyte proliferation to mitogenic stimuli. Clinical & Investigative Medicine 15(4 Suppl.): A63, 1992

Modulation of human lymphocyte proliferation by ursodeoxycholic acid udca. Hepatology 14(4 Part 2): 167A, 1991

Effects of ursodeoxycholic acid udca on mucin secretion of the gallbladder a mechanisms whereby udca prolongs cholesterol crystal nucleation. Gastroenterology 100(5 Part 2): A804, 1991

Influence of ursodeoxycholic acid udca on hepatocyte proliferation in vitro. Journal of Hepatology 13(Suppl. 2): S8, 1991

Investigations in the therapeutical mechanisms of ursodeoxycholic acid udca in liver therapy. Gastroenterology 96(5 Part 2): A617, 1989

Symptomatic gallstones are likely to reoccur after dissolution with ursodeoxycholic acid udca but this may be prevented by low dose udca. Gastroenterology 92(5 Part 2): 1787, 1987

Effects of lovastatin ls ursodeoxycholic acid udca and ls plus udca on bile lipid composition in patients with cholesterol ch gallstones. Gastroenterology 102(4 Part 2): A319, 1992

Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes. Alimentary Pharmacology and Therapeutics 43(2): 283-293, 2016

Biliary secretion of ursodeoxycholic acid udca taurine and glycine conjugates sulfates and glucuronides in patients with external biliary drainage. Hepatology 14(4 Part 2): 260A, 1991

Increased concentration of ursodeoxycholic acid in fecal water during UDCA therapy may cause the colon cancer chemoprevention effects of UDCA by enhancing apoptosis. Gastroenterology 112(4 Suppl. ): A610, 1997

A simple rapid and non invasive test of compliance to oral ursodeoxycholic acid udca therapy detection of udca sulfate a specific urinary metabolite. Hepatology 14(4 Part 2): 261A, 1991

Increased liver tissue ursodeoxycholic acid concentration and reduced lithocholate formation in rats orally administered the taurine conjugate of UDCA compared with unconjugated UDCA. Gastroenterology 108(4 Suppl. ): A1156, 1995

Chenodeoxycholic acid cdca induces the hepatic synthesis of ursodeoxycholic acid udca by guinea pigs in contrast biosynthesis of cdca by the liver is suppressed by cdca but increased by udca. Gastroenterology 102(4 Part 2): A901, 1992

Activation of transcriptional factors stat5 and stat3 during human T-lymphocyte proliferation induced by different mitogenic stimuli. Tsitologiia 48(1): 42-49, 2006